Activation of Blood Clotting and Inhibition of Fibrinolysis in Acute Pancreatitis

Summary

The following changes in patients and dogs with acute pancreatitis or pancreatic necrosis were observed: shortening the plastic and glass clotting time, decrease of factor V, transistory decrease of fibrinogen followed by an increase of this factor, inhibition of euglobulin fibrinolysis, increase of plasminogen and antiplasmin.

Autopsy examinations revealed many thrombi in pancreas and in other organs in dogs as well in humans.

The authors emphasized the similarity between Shwartzman phenomenon and acute pancreatitis and suggest that heparin should be used in the prevention and treatment of acute pancreatitis in human.

• References

• 1 Bernard A. New ideas in the physiopathology and treatment of acute pancreatitis. Triangle (En.) 1966; 7: 170
• 2 Dick W, Matis P, Mayer W, Möri F.K, Naegeli Th. Zur Bedeutung von Proteinasen-Inhibitoren für die Thromboembolie-Prophylaxe. Med. Welt 1967: 1835
• 3 Douglas S.R, Colebrook L. Trypsin in Blood Cultures. Lancet 1916; II: 180
• 4 Eagle H, Harris N. Studies in Blood Coagulation: The Coagulation of Blood by Proteolytic Enzymes (Trypsin and Papain). J. gen. Physiol 1936; 37 20: 543
• 5 Elliott W.D, Williams R.D, Zollinger R.M. Alterations in the pancreatic resistance to bile in the pathogenesis of acute pancreatitis. Ann. Surg 1957; 146: 669
• 6 Encke A, Schimpf Kl, Konunerell B, Grözinger K.H, Gilsdorf H, Wanke M, Lasch H.G. Veränderungen der Blutgerinnung bei der akuten experimentellen Pancreatitis des Hundes. Klin. Wschr 1966; 44: 90
• 7 Gabryelewicz A, Niewiarowski S, Prokopowicz J, Ghlebowski J. Heparin and protease inhibitors in the prevention of experimental acute pancreatitis. Digestion.(In press).
• 8 Gert L, Matis P. Trasylol, ein Proteinaseninhibitor bei chirurgischen und internen Indikationen. Med. Welt. 1967: 1367
• 9 Howard J.M. Surgical management of acute pancreatitis. J. Amer. med. Ass 1960; 174: 1687
• 10 Kowalski E, Kopeć M, Niewiarowski S. An evaluation of the euglobulin method for the determination of fibrinolysis. J. clin. Path 1959; 12: 215
• 11 Lassen M. Heat denaturation of plasminogen in the fibrin plate method. Acta physiol. scand 1952; 27: 371
• 12 Lee R.I, White P.D. A clinical study of the coagulation of blood. Amer. J. med. Sci 1913; 145: 495
• 13 Lukasiewicz H, Olszewski W, Rowiński W, Nielubowicz J. Disturbances in blood coagulation and fibrinolysis under the influence of pancreatic juice. Bull. Acad. pol. Sci. Cl. VI 1965; 12: 2
• 14 Miller J.M, Opher A.W. The reaction between trypsin and human blood. Exp. Med. Surg 1965; 419: 421
• 15 Nardi G.L. Ch, Less W. A new diagnostic test for pancreatic disease. New. Engl. J. Med 1958; 258: 797
• 16 Quick A.J. The physiology and pathology of haemostasis. Henry Kimpton; London: 1951
• 17 Shinowara G.Y, Stutman L.J, Walters M.I, Ruth M.E, Walker E.J. Hypercoagulability in acute pancreatitis. Amer. J. Surg 1963; 714: 719
• 18 Stetson C.A. Studies on the mechanism of the Shwartzman Phenomenon; certain Factors involved in the production of the local haemorrhagic necrosis. J. exp. Med 1951; 93: 489
• 19 Storer J. Ph. Kazdan: The relation of the pancreas to blood coagulation. Surgery 1953; 683: 689
• 20 Thal Al, Brackney E. Acute hemorrhagic pancreatitic necrosis produced by local Shwartzman reaction. J. Amer. med. Ass 1954; 155: 569
• 21 Wolf P. A modification for routine laboratory use Stefanini's method of estimation factor V activity in human oxalated plasma. J. clin. Pathol 1953; 6: 34